115 related articles for article (PubMed ID: 9683773)
1. Novel vitamin D3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo.
Koshizuka K; Koike M; Kubota T; Said J; Binderup L; Koeffler HP
Int J Oncol; 1998 Sep; 13(3):421-8. PubMed ID: 9683773
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo.
Koshizuka K; Koike M; Asou H; Cho SK; Stephen T; Rude RK; Binderup L; Uskokovic M; Koeffler HP
Breast Cancer Res Treat; 1999 Jan; 53(2):113-20. PubMed ID: 10326788
[TBL] [Abstract][Full Text] [Related]
3. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
4. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
Danielsson C; Mathiasen IS; James SY; Nayeri S; Bretting C; Hansen CM; Colston KW; Carlberg C
J Cell Biochem; 1997 Sep; 66(4):552-62. PubMed ID: 9282333
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice.
Koshizuka K; Kubota T; Said J; Koike M; Binderup L; Uskokovic M; Koeffler HP
Anticancer Res; 1999; 19(1A):519-24. PubMed ID: 10226591
[TBL] [Abstract][Full Text] [Related]
6. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
[TBL] [Abstract][Full Text] [Related]
9. Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells.
Kodali S; Burkley M; Nag K; Taylor RC; Moudgil VK
Biochem Biophys Res Commun; 1994 Aug; 202(3):1413-9. PubMed ID: 7914723
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
11. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
12. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].
Yamada Y; Saito H; Oie S; Takechi T; Nakano K; Takeda S
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1327-31. PubMed ID: 2114827
[TBL] [Abstract][Full Text] [Related]
15. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
Vadgama JV; Wu Y; Shen D; Hsia S; Block J
Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Chahinian AP; Mandeli JP; Gluck H; Naim H; Teirstein AS; Holland JF
J Surg Oncol; 1998 Feb; 67(2):104-11. PubMed ID: 9486781
[TBL] [Abstract][Full Text] [Related]
17. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
[TBL] [Abstract][Full Text] [Related]
19. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
Yan XD; Li M; Yuan Y; Mao N; Pan LY
Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
[TBL] [Abstract][Full Text] [Related]
20. Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis.
Pirianov G; Colston KW
Mol Cell Endocrinol; 2001 Feb; 172(1-2):69-78. PubMed ID: 11165041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
